vs
AtriCure, Inc.（ATRC）与Purple Innovation, Inc.（PRPL）财务数据对比。点击上方公司名可切换其他公司
Purple Innovation, Inc.的季度营收约是AtriCure, Inc.的1.0倍（$140.7M vs $140.5M），AtriCure, Inc.同比增速更快（13.1% vs 9.1%），AtriCure, Inc.自由现金流更多（$18.4M vs $-7.8M），过去两年AtriCure, Inc.的营收复合增速更高（13.6% vs 8.3%）
AtriCure是一家专注于心房颤动及相关心脏病症治疗的医疗设备企业，研发并生产创新外科手术工具与疗法，主要服务北美、欧洲、亚太地区的医院、心脏外科中心及医疗机构，为微创心脏手术提供高效可靠的适配解决方案。
Purple Carrot是一家总部位于马萨诸塞州尼达姆市的全植物性餐包品牌，由安迪·莱维特创立，每周为订阅用户提供预制餐品和自制餐包。据《大都会》2022年报道，对比美式标准餐食，该品牌每份餐包的碳排放量可降低72%，主打低碳环保的纯植物饮食方案。
ATRC vs PRPL — 直观对比
营收规模更大
PRPL
是对方的1.0倍
$140.5M
营收增速更快
ATRC
高出4.0%
9.1%
自由现金流更多
ATRC
多$26.2M
$-7.8M
两年增速更快
ATRC
近两年复合增速
8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.5M | $140.7M |
| 净利润 | — | $-3.2M |
| 毛利率 | 75.0% | 41.9% |
| 营业利润率 | 1.8% | -1.6% |
| 净利率 | — | -2.3% |
| 营收同比 | 13.1% | 9.1% |
| 净利润同比 | — | 62.1% |
| 每股收益（稀释后） | $0.04 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCPRPL
| Q4 25 | $140.5M | $140.7M | ||
| Q3 25 | $134.3M | $118.8M | ||
| Q2 25 | $136.1M | $105.1M | ||
| Q1 25 | $123.6M | $104.2M | ||
| Q4 24 | $124.3M | $129.0M | ||
| Q3 24 | $115.9M | $118.6M | ||
| Q2 24 | $116.3M | $120.3M | ||
| Q1 24 | $108.9M | $120.0M |
净利润ATRCPRPL
| Q4 25 | — | $-3.2M | ||
| Q3 25 | $-267.0K | $-11.7M | ||
| Q2 25 | $-6.2M | $-17.3M | ||
| Q1 25 | $-6.7M | $-19.1M | ||
| Q4 24 | — | $-8.5M | ||
| Q3 24 | $-7.9M | $-39.2M | ||
| Q2 24 | $-8.0M | $27.0K | ||
| Q1 24 | $-13.3M | $-50.2M |
毛利率ATRCPRPL
| Q4 25 | 75.0% | 41.9% | ||
| Q3 25 | 75.5% | 42.8% | ||
| Q2 25 | 74.5% | 35.9% | ||
| Q1 25 | 74.9% | 39.4% | ||
| Q4 24 | 74.5% | 42.9% | ||
| Q3 24 | 74.9% | 29.7% | ||
| Q2 24 | 74.7% | 40.7% | ||
| Q1 24 | 74.7% | 34.8% |
营业利润率ATRCPRPL
| Q4 25 | 1.8% | -1.6% | ||
| Q3 25 | 0.2% | -10.2% | ||
| Q2 25 | -4.5% | -13.5% | ||
| Q1 25 | -4.8% | -13.9% | ||
| Q4 24 | -11.7% | -6.0% | ||
| Q3 24 | -6.4% | -39.5% | ||
| Q2 24 | -6.2% | -12.1% | ||
| Q1 24 | -10.0% | -19.3% |
净利率ATRCPRPL
| Q4 25 | — | -2.3% | ||
| Q3 25 | -0.2% | -9.9% | ||
| Q2 25 | -4.5% | -16.5% | ||
| Q1 25 | -5.5% | -18.4% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | -6.8% | -33.1% | ||
| Q2 24 | -6.9% | 0.0% | ||
| Q1 24 | -12.2% | -41.8% |
每股收益（稀释后）ATRCPRPL
| Q4 25 | $0.04 | $0.03 | ||
| Q3 25 | $-0.01 | $0.11 | ||
| Q2 25 | $-0.13 | $0.16 | ||
| Q1 25 | $-0.14 | $0.18 | ||
| Q4 24 | $-0.33 | $0.08 | ||
| Q3 24 | $-0.17 | $0.36 | ||
| Q2 24 | $-0.17 | $0.00 | ||
| Q1 24 | $-0.28 | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.4M | $24.3M |
| 总债务越低越好 | — | $126.7M |
| 股东权益账面价值 | $491.9M | $-29.7M |
| 总资产 | $654.2M | $296.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATRCPRPL
| Q4 25 | $167.4M | $24.3M | ||
| Q3 25 | $147.9M | $32.4M | ||
| Q2 25 | $117.8M | $34.2M | ||
| Q1 25 | $99.9M | $21.6M | ||
| Q4 24 | $122.7M | $29.0M | ||
| Q3 24 | $130.3M | $23.4M | ||
| Q2 24 | $114.0M | $23.4M | ||
| Q1 24 | $106.0M | $34.5M |
总债务ATRCPRPL
| Q4 25 | — | $126.7M | ||
| Q3 25 | $61.9M | — | ||
| Q2 25 | $61.9M | — | ||
| Q1 25 | $61.9M | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | $61.9M | $50.8M | ||
| Q2 24 | $61.9M | — | ||
| Q1 24 | $61.9M | — |
股东权益ATRCPRPL
| Q4 25 | $491.9M | $-29.7M | ||
| Q3 25 | $476.5M | $-26.9M | ||
| Q2 25 | $464.5M | $-15.6M | ||
| Q1 25 | $454.6M | $1.3M | ||
| Q4 24 | $461.0M | $20.2M | ||
| Q3 24 | $465.0M | $28.0M | ||
| Q2 24 | $462.1M | $66.4M | ||
| Q1 24 | $456.3M | $65.5M |
总资产ATRCPRPL
| Q4 25 | $654.2M | $296.3M | ||
| Q3 25 | $635.4M | $302.1M | ||
| Q2 25 | $608.8M | $303.8M | ||
| Q1 25 | $591.6M | $293.8M | ||
| Q4 24 | $609.3M | $307.8M | ||
| Q3 24 | $615.1M | $309.3M | ||
| Q2 24 | $597.3M | $362.1M | ||
| Q1 24 | $591.6M | $382.1M |
负债/权益比ATRCPRPL
| Q4 25 | — | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | 0.13× | 1.82× | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | $-5.8M |
| 自由现金流经营现金流 - 资本支出 | $18.4M | $-7.8M |
| 自由现金流率自由现金流/营收 | 13.1% | -5.5% |
| 资本支出强度资本支出/营收 | 1.1% | 1.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $48.3M | $-41.9M |
8季度趋势，按日历期对齐
经营现金流ATRCPRPL
| Q4 25 | $20.0M | $-5.8M | ||
| Q3 25 | $26.7M | $-968.0K | ||
| Q2 25 | $21.6M | $-4.0M | ||
| Q1 25 | $-11.0M | $-23.1M | ||
| Q4 24 | $5.8M | $6.8M | ||
| Q3 24 | $20.0M | $1.1M | ||
| Q2 24 | $7.4M | $-8.9M | ||
| Q1 24 | $-21.0M | $-16.8M |
自由现金流ATRCPRPL
| Q4 25 | $18.4M | $-7.8M | ||
| Q3 25 | $24.1M | $-1.8M | ||
| Q2 25 | $19.0M | $-7.0M | ||
| Q1 25 | $-13.2M | $-25.3M | ||
| Q4 24 | $3.1M | $5.7M | ||
| Q3 24 | $16.4M | $101.0K | ||
| Q2 24 | $5.0M | $-11.0M | ||
| Q1 24 | $-23.8M | $-19.9M |
自由现金流率ATRCPRPL
| Q4 25 | 13.1% | -5.5% | ||
| Q3 25 | 18.0% | -1.5% | ||
| Q2 25 | 13.9% | -6.6% | ||
| Q1 25 | -10.7% | -24.3% | ||
| Q4 24 | 2.5% | 4.4% | ||
| Q3 24 | 14.1% | 0.1% | ||
| Q2 24 | 4.3% | -9.2% | ||
| Q1 24 | -21.9% | -16.5% |
资本支出强度ATRCPRPL
| Q4 25 | 1.1% | 1.4% | ||
| Q3 25 | 1.9% | 0.7% | ||
| Q2 25 | 2.0% | 2.8% | ||
| Q1 25 | 1.8% | 2.2% | ||
| Q4 24 | 2.2% | 0.8% | ||
| Q3 24 | 3.1% | 0.9% | ||
| Q2 24 | 2.1% | 1.7% | ||
| Q1 24 | 2.5% | 2.5% |
现金转化率ATRCPRPL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRC
| Appendage Management | $45.5M | 32% |
| Openheart | $38.5M | 27% |
| Other | $26.2M | 19% |
| Pain Management | $22.6M | 16% |
| Minimally Invasive | $7.7M | 6% |
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
